The DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.
Enzyme replacement and enhancement therapies: lessons from lysosomal disorders
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Metabolic and Molecular Bases of Inherited Disease
Scriver, R. C. (1995) · Medical Entomology and Zoology · Cited by 12,101
Lodish, H. F. (1986) · Cited by 5,650
Identification of the Cystic Fibrosis Gene: Genetic Analysis
Kerem, B.-S., Rommens, J. M., Buchanan, J. A., Markiewicz, D., Cox, T. K., Chakravarti, A., Buchwald, M., & Tsui, L.-C. (1989) · Science · doi:10.1126/science.2570460 · Cited by 4,142
Prevalence of lysosomal storage disorders
Meikle, P. J. (1999) · JAMA · doi:10.1001/jama.281.3.249 · Cited by 2,197
Kornfeld, S., & Mellman, I. (1989) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.05.110189.002411 · Cited by 1,580
Safety and Efficacy of Recombinant Human α-Galactosidase A Replacement Therapy in Fabry's Disease
Eng, C. M., Guffon, N., Wilcox, W. R., Germain, D. P., Lee, P., Waldek, S., Caplan, L., Linthorst, G. E., & Desnick, R. J. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107053450102 · Cited by 1,559
Self-citationEnzyme Replacement Therapy in Fabry Disease: A Randomized Controlled Trial
Schiffmann, R., Kopp, J. B., Austin III, H. A., Sabnis, S., Moore, D. F., Weibel, T., Balow, J. E., & Brady, R. O. (2001) · JAMA · doi:10.1001/jama.285.21.2743 · Cited by 1,302
Barton, N. W., Brady, R. O., Dambrosia, J. M., Di Bisceglie, A. M., Doppelt, S. H., Hill, S. C., Mankin, H. J., Murray, G. J., Parker, R. I., Argoff, C. E., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199105233242104 · Cited by 1,252
Toxic Proteins in Neurodegenerative Disease
Taylor, J. P., Hardy, J., & Fischbeck, K. H. (2002) · Science · doi:10.1126/science.1067122 · Cited by 1,251
STRUCTURE AND FUNCTION OF THE MANNOSE 6-PHOSPHATE/INSULINLIKE GROWTH FACTOR II RECEPTORS
Kornfeld, S. (1992) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.61.070192.001515 · Cited by 1,092
Enzyme-Replacement Therapy in Mucopolysaccharidosis I
Kakkis, E. D., Muenzer, J., Tiller, G. E., Waber, L., Belmont, J., Passage, M., Izykowski, B., Phillips, J., Doroshow, R., Walot, I., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200101183440304 · Cited by 667
Walker, J. H. (1997) · Biochemical Education · doi:10.1016/s0307-4412(97)88293-3 · Cited by 659
Fan, J.-Q., Ishii, S., Asano, N., & Suzuki, Y. (1999) · Nature Medicine · doi:10.1038/4801 · Cited by 614
Kaplan, A., Achord, D. T., & Sly, W. S. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.5.2026 · Cited by 574
Morello, J.-P., Salahpour, A., Laperrière, A., Bernier, V., Arthus, M.-F., Lonergan, M., Petäjä-Repo, U., Angers, S., Morin, D., Bichet, D. G., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8688 · Cited by 565
Weinreb, N. J., Charrow, J., Andersson, H. C., Kaplan, P., Kolodny, E. H., Mistry, P., Pastores, G., Rosenbloom, B. E., Scott, C. R., Wappner, R. S., et al. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01150-6 · Cited by 546
Glycerol Reverses the Misfolding Phenotype of the Most Common Cystic Fibrosis Mutation
Sato, S., Ward, C. L., Krouse, M. E., Wine, J. J., & Kopito, R. R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.2.635 · Cited by 519
Influence of molecular and chemical chaperones on protein folding
Welch, W. J., & Brown, C. R. (1996) · Cell Stress & Chaperones · doi:10.1379/1466-1268(1996)001<0109:iomacc>2.3.co;2 · Cited by 495
SAFETY AND EFFICACY OF RECOMBINANT HUMAN a -GALACTOSIDASE A REPLACEMENT THERAPY IN FABRY'S DISEASE
Ng, M., Uffon, N. A. G., Ilcox, W. I. R. W., Ermain, P. G., Ee, P., Aldek, S. T. W., Aplan, L. O. C., Inthorst, E. L., & Esnick, R. O. J. D. (2001) · Cited by 482
Sango, K., Yamanaka, S., Hoffmann, A., Okuda, Y., Grinberg, A., Westphal, H., McDonald, M. P., Crawley, J. N., Sandhoff, K., Suzuki, K., et al. (1995) · Nature Genetics · doi:10.1038/ng1095-170 · Cited by 468
Alpha1-Antitrypsin Deficiency — A Model for Conformational Diseases
Carrell, R. W., & Lomas, D. A. (2002) · New England Journal of Medicine · doi:10.1056/nejmra010772 · Cited by 448
Grabowski, G. A., Barton, N. W., Pastores, G., Dambrosia, J. M., Banerjee, T. K., McKee, M. A., Parker, C., Schiffmann, R., Hill, S. C., & Brady, R. O. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-122-1-199501010-00005 · Cited by 446
A hypothesis for I-cell disease: Defective hydrolases that do not enter lysosomes
Hickman, S., & Neufeld, E. F. (1972) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(72)90310-5 · Cited by 444
Burrows, J. A. J., Willis, L. K., & Perlmutter, D. H. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.4.1796 · Cited by 426
Brown, C. R., Hong-Brown, L. Q., Biwersi, J., Verkman, A. S., & Welch, W. J. (1996) · Cell Stress & Chaperones · doi:10.1379/1466-1268(1996)001<0117:ccctmp>2.3.co;2 · Cited by 417
ER-associated degradation in protein quality control and cellular regulation
Hampton, R. Y. (2002) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(02)00358-7 · Cited by 415
Rubenstein, R. C., Egan, M. E., & Zeitlin, P. L. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119788 · Cited by 389
Eng, C. M., Banikazemi, M., Gordon, R. E., Goldman, M., Phelps, R., Kim, L., Gass, A., Winston, J., Dikman, S., Fallon, J. T., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/318809 · Cited by 385
Self-citationα-Galactosidase A deficient mice: A model of Fabry disease
Ohshima, T., Murray, G. J., Swaim, W. D., Longenecker, G., Quirk, J. M., Cardarelli, C. O., Sugimoto, Y., Pastan, I., Gottesman, M. M., Brady, R. O., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2540 · Cited by 367
Barton, N. W., Furbish, F. S., Murray, G. J., Garfield, M., & Brady, R. O. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1913 · Cited by 366
(1988) · Springer eBooks · doi:10.1007/978-1-4613-0987-1 · Cited by 358
Amalfitano, A., Bengur, A. R., Morse, R. P., Majure, J. M., Case, L. E., Veerling, D. L., Mackey, J., Kishnani, P., Smith, W., McVie-Wylie, A., et al. (2001) · Genetics in Medicine · doi:10.1038/gim200127 · Cited by 347
Schiffmann, R., Murray, G. J., Treco, D., Daniel, P., Sellos-Moura, M., Myers, M., Quirk, J. M., Zirzow, G. C., Borowski, M., Loveday, K., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.1.365 · Cited by 342
Frustaci, A., Chimenti, C., Ricci, R., Natale, L., Russo, M. A., Pieroni, M., Eng, C. M., & Desnick, R. J. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107053450104 · Cited by 332
Self-citationBrady, R. O., Tallman, J. F., Johnson, W. G., Gal, A. E., Leahy, W. R., Quirk, J. M., & Dekaban, A. S. (1973) · New England Journal of Medicine · doi:10.1056/nejm197307052890103 · Cited by 312
Animal model of Gaucher's disease from targeted disruption of the mouse glucocerebrosidase gene
Tybulewicz, V. L. J., Tremblay, M. L., LaMarca, Willemsen, R., Stubblefield, B. K., Winfield, S., Zablocka, B., Sidransky, E., Martin, B. M., Huang, S. P., et al. (1992) · Nature · doi:10.1038/357407a0 · Cited by 308
Raben, N., Nagaraju, K., Lee, E., Kessler, P., Byrne, B., Lee, L., LaMarca, M., King, C., Ward, J., Sauer, B., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.30.19086 · Cited by 299
Brady, R. O., Pentchev, P. G., Gal, A. E., Hibbert, S. R., & Dekaban, A. S. (1974) · New England Journal of Medicine · doi:10.1056/nejm197411072911901 · Cited by 294
Phenotype of arylsulfatase A-deficient mice: Relationship to human metachromatic leukodystrophy
Hess, B., Saftig, P., Hartmann, D., Coenen, R., Lüllmann-Rauch, R., Goebel, H. H., Evers, M., von Figura, K., D’Hooge, R., Nagels, G., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.25.14821 · Cited by 264
Mannose 6-phosphate receptors in sorting and transport of lysosomal enzymes
Hille-Rehfeld, A. (1995) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(95)00004-b · Cited by 249
Asano, N., Ishii, S., Kizu, H., Ikeda, K., Yasuda, K., Kato, A., Martin, O. R., & Fan, J. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01457.x · Cited by 242
Pharmacological chaperones: a new twist on receptor folding
Morello, J.-P., Bouvier, M., Petäjä-Repo, U. E., & Bichet, D. G. (2000) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01575-3 · Cited by 241
mRNA surveillance: the perfect persist
Wagner, E., & Lykke-Andersen, J. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.15.3033 · Cited by 238
Correction of Defective Protein Kinesis of Human P-glycoprotein Mutants by Substrates and Modulators
Loo, T. W., & Clarke, D. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.2.709 · Cited by 224
Li, H. H., Yu, W.-H., Rozengurt, N., Zhao, H.-Z., Lyons, K. M., Anagnostaras, S., Fanselow, M. S., Suzuki, K., Vanier, M. T., & Neufeld, E. F. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.25.14505 · Cited by 210
Otterbach, B., & Stoffel, W. (1995) · Cell · doi:10.1016/s0092-8674(05)80010-8 · Cited by 209
KORNFELD, S. (1990) · Biochemical Society Transactions · doi:10.1042/bst0180367 · Cited by 207
Ioannou, Y. A., Zeidner, K. M., Gordon, R. E., & Desnick, R. J. (2001) · The American Journal of Human Genetics · doi:10.1086/316953 · Cited by 200
Self-citationBaraitser, M. (1981) · Journal of Medical Genetics · doi:10.1136/jmg.18.1.77 · Cited by 197
A mouse model for mucopolysaccharidosis type III A (Sanfilippo syndrome)
Bhaumik, M., Muller, V. J., Rozaklis, T., Linda, J., Dobrenis, K., Bhattacharyya, R., Wurzelmann, S., Finamore, P., Hopwood, J. J., Walkley, S. U., et al. (1999) · Glycobiology · doi:10.1093/glycob/9.12.1389 · Cited by 189
Enzyme therapy for Gaucher disease: the first 5 years
Grabowski, G. A., Leslie, N., & Wenstrup, R. (1998) · Blood Reviews · doi:10.1016/s0268-960x(98)90023-6 · Cited by 188
Sahagian, G. G., Distler, J., & Jourdian, G. W. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.7.4289 · Cited by 176
Murine mucopolysaccharidosis type I: targeted disruption of the murine alpha-L-iduronidase gene
Clarke, L. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.4.503 · Cited by 175
deDuve, C. (1996) · PubMed · Cited by 174
Enzyme therapy for Pompe disease with recombinant human α‐glucosidase from rabbit milk
Van den Hout, J. M. P., Reuser, A. J. J., de Klerk, J. B. C., Arts, W. F., Smeitink, J. A. M., & Van der Ploeg, A. T. (2001) · Journal of Inherited Metabolic Disease · doi:10.1023/a:1010383421286 · Cited by 172
The efficacy of enzyme replacement therapy in patients with chronic neuronopathic Gaucher’s disease
Altarescu, G., Hill, S., Wiggs, E., Jeffries, N., Kreps, C., Parker, C. C., Brady, R. O., Barton, N. W., & Schiffmann, R. (2001) · The Journal of Pediatrics · doi:10.1067/mpd.2001.112171 · Cited by 167
Holtzman, E. (1989) · Springer eBooks · doi:10.1007/978-1-4899-2540-4 · Cited by 154
Sidransky, E., Sherer, D. M., & Ginns, E. I. (1992) · Pediatric Research · doi:10.1203/00006450-199210000-00023 · Cited by 146
Generalized glycogen storage and cardiomegaly in a knockout mouse model of Pompe disease
Bijvoet, A. G. A., van de Kamp, E. H. M., Kroos, M. A., Ding, J. H., Yang, B.-Z., de Visser, P. J., Bakker, C. E., Verbeet, M. P., Oostra, B. A., Reuser, A. J. J., et al. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.1.53 · Cited by 143
Vogler, C. A., Birkenmeier, E. H., Sly, W. S., Levy, B. K., Pegors, C., Kyle, J. W., & Beamer, W. G. (1990) · PubMed · Cited by 142
Miranda, S. R. P., He, X., Simonaro, C. M., Gátt, S., Dagan, A., Desnick, R. J., & Schuchman, E. H. (2000) · The FASEB Journal · doi:10.1096/fj.00-0014com · Cited by 140
Self-citationIoannou, Y. A., Bishop, D. F., & Desnick, R. J. (1992) · The Journal of Cell Biology · doi:10.1083/jcb.119.5.1137 · Cited by 137
Self-citationEnzyme therapy in genetic diseases
Gregoriadis, G., & Dean, M. F. (1979) · Nature · doi:10.1038/278603a0 · Cited by 134
Bijvoet, A. G. A., Hirtum, H. V., Kroos, M. A., van de Kamp, E. H. M., Schoneveld, O., de Visser, P. J., Brakenhoff, J. P. J., Weggeman, M., van Corven, E. J., van der Ploeg, A. T., et al. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.12.2145 · Cited by 125
Bioproduction of Human Enzymes in Transgenic Tobaccoa
Cramer, C. L., Weissenborn, D. L., Oishi, K. K., Grabau, E. A., Bennett, S., Ponce, E., Grabowski, G. A., & Radin, D. N. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb32492.x · Cited by 120
Tsushima, H., Kawata, S., Tamura, S., Ito, N., Shirai, Y., Kiso, S., Doi, Y., Yamada, A., Oshikawa, O., & Matsuzawa, Y. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80001-4 · Cited by 118
Barton, R. W., & Neufeld, E. F. (1971) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)45842-0 · Cited by 112
Takahashi, H., Hirai, Y., Migita, M., Seino, Y., Fukuda, Y., Sakuraba, H., Kase, R., Kobayashi, T., Hashimoto, Y., & Shimada, T. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.222221899 · Cited by 102
Galactose Stabilizes Various Missense Mutants of α-Galactosidase in Fabry Disease
Okumiya, T., Ishii, S., Takenaka, T., Kase, R., Kamei, S., Sakuraba, H., & Suzuki, Y. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2416 · Cited by 101
Porter, M. T., Fluharty, A. L., & Kihara, H. (1971) · Science · doi:10.1126/science.172.3989.1263 · Cited by 99
Vogler, C. A., Levy, B. K., Galvin, N. J., Thorpe, C., Sands, M. S., Barker, J. E., Baty, J., Birkenmeier, E. H., & Sly, W. S. (1999) · Pediatric Research · doi:10.1203/00006450-199906000-00010 · Cited by 98
Enzyme therapy for lysosomal acid lipase deficiency in the mouse
Du, H. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.16.1639 · Cited by 95
Evers, M., Säftig, P., Schmidt, P. M., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8214 · Cited by 91
Read, A. (1992) · Neuromuscular Disorders · doi:10.1016/0960-8966(92)90012-u · Cited by 85
Enhanced macrophage uptake of synthetically glycosylated human placental beta-glucocerebrosidase.
Doebber, T. W., Wu, M. S., Bugianesi, R. L., Ponpipom, M. M., Furbish, F. S., Barranger, J. A., Brady, R. O., & Shen, T. Y. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34905-6 · Cited by 84
Sanfilippo Disease Type B: Enzyme Replacement and Metabolic Correction in Cultured Fibroblasts
O′Brien, J. S., Miller, A. L., Loverde, A. W., & Veath, M. L. (1973) · Science · doi:10.1126/science.181.4101.753 · Cited by 81
Sands, M. S., Vogler, C. A., Ohlemiller, K. K., Roberts, M. S., Grubb, J. H., Levy, B. K., & Sly, W. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107778200 · Cited by 71
Platt, F. M., & Butters, T. D. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00115-4 · Cited by 70
Enzyme replacement in Tay‐Sachs disease
von Specht, B. U., Geiger, B., Arnon, R., PASSWELL, J. H., Keren, G., Goldman, B., & Padeh, B. (1979) · Neurology · doi:10.1212/wnl.29.6.848 · Cited by 61
Brooks, D. A. (1999) · Molecular Genetics and Metabolism · doi:10.1006/mgme.1999.2894 · Cited by 59
Miranda, S. R. P., Erlich, S. S., Friedrich, V. L., et al. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301300 · Cited by 58
Gene therapy for the lysosomal storage disorders.
Cabrera-Salazar, M. A., Novelli, E. M., & Barranger, J. A. (2002) · PubMed · Cited by 51
Specificity of Mouse GM2 Activator Protein and β-N-Acetylhexosaminidases A and B
Yuziuk, J. A., Bertoni, C., Beccari, T., Orlacchio, A., Wu, Y., Li, S., & Li, Y. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.1.66 · Cited by 48
Sly, W. S., & Vogler, C. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.102175599 · Cited by 48
Marathe, S. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.13.1967 · Cited by 47
An Inducible Mouse Model of Late Onset Tay–Sachs Disease
Jeyakumar, M., Smith, D. A., Eliott-Smith, E., Cortina‐Borja, M., Reinkensmeier, G., Butters, T. D., Lemm, T., Sandhoff, K., Perry, V. H., Dwek, R. A., et al. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0511 · Cited by 30
Welch, W. J., & Howard, M. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9158 · Cited by 28
Cited by
Exosomes as drug delivery vehicles for Parkinson’s disease therapy
Haney, M. J., Klyachko, N. L., Zhao, Y., Gupta, R., Plotnikova, E. G., He, Z., Patel, T., Piroyan, A., Sokolsky, M., Kabanov, A. V., et al. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.03.033 · Cited by 2,009
High Incidence of Later-Onset Fabry Disease Revealed by Newborn Screening*
Spada, M., Pagliardini, S., Yasuda, M., Tukel, T., Thiagarajan, G., Sakuraba, H., Ponzone, A., & Desnick, R. J. (2006) · The American Journal of Human Genetics · doi:10.1086/504601 · Cited by 1,008
Self-citationHuman and mouse proteases: a comparative genomic approach
Puente, X. S., Sánchez, L. M., Overall, C. M., & López-Otín, C. (2003) · Nature Reviews Genetics · doi:10.1038/nrg1111 · Cited by 943
Emerging roles of proteases in tumour suppression
López-Otín, C., & Matrisian, L. M. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2228 · Cited by 802
The cell biology of lysosomal storage disorders
Futerman, A. H., & van Meer, G. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1423 · Cited by 796
Metadata
- Authors
- Desnick, R. J., & Schuchman, E. H.
- Venue
- Nature Reviews Genetics
- Published
- 2002-12-01
- Volume
- 3
- Issue
- 12
- Pages
- 954-966
- ISSN
- 1471-0056 (ISSN-L)
- 1471-0064
- OpenAlex
- W2024420787
- Cited by
- 268
- References
- 87
- FWCI
- 1.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.